Logo image of SXT

SENSIENT TECHNOLOGIES CORP (SXT) Stock Fundamental Analysis

NYSE:SXT - New York Stock Exchange, Inc. - US81725T1007 - Common Stock - Currency: USD

94.49  -0.04 (-0.04%)

After market: 94.49 0 (0%)

Fundamental Rating

6

Overall SXT gets a fundamental rating of 6 out of 10. We evaluated SXT against 85 industry peers in the Chemicals industry. SXT scores excellent on profitability, but there are some minor concerns on its financial health. SXT is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year SXT was profitable.
SXT had a positive operating cash flow in the past year.
Each year in the past 5 years SXT has been profitable.
In the past 5 years SXT always reported a positive cash flow from operatings.
SXT Yearly Net Income VS EBIT VS OCF VS FCFSXT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M 200M

1.2 Ratios

With an excellent Return On Assets value of 6.13%, SXT belongs to the best of the industry, outperforming 84.71% of the companies in the same industry.
With an excellent Return On Equity value of 11.71%, SXT belongs to the best of the industry, outperforming 82.35% of the companies in the same industry.
SXT's Return On Invested Capital of 8.07% is fine compared to the rest of the industry. SXT outperforms 72.94% of its industry peers.
SXT had an Average Return On Invested Capital over the past 3 years of 8.07%. This is in line with the industry average of 6.86%.
Industry RankSector Rank
ROA 6.13%
ROE 11.71%
ROIC 8.07%
ROA(3y)5.97%
ROA(5y)6.2%
ROE(3y)11.57%
ROE(5y)11.82%
ROIC(3y)8.07%
ROIC(5y)8.29%
SXT Yearly ROA, ROE, ROICSXT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

The Profit Margin of SXT (8.19%) is better than 81.18% of its industry peers.
SXT's Profit Margin has improved in the last couple of years.
SXT's Operating Margin of 12.93% is fine compared to the rest of the industry. SXT outperforms 70.59% of its industry peers.
SXT's Operating Margin has improved in the last couple of years.
SXT has a Gross Margin of 32.93%. This is in the better half of the industry: SXT outperforms 62.35% of its industry peers.
In the last couple of years the Gross Margin of SXT has remained more or less at the same level.
Industry RankSector Rank
OM 12.93%
PM (TTM) 8.19%
GM 32.93%
OM growth 3Y-1.22%
OM growth 5Y6.81%
PM growth 3Y-2.37%
PM growth 5Y5.25%
GM growth 3Y-0.3%
GM growth 5Y0.81%
SXT Yearly Profit, Operating, Gross MarginsSXT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SXT is destroying value.
Compared to 1 year ago, SXT has more shares outstanding
The number of shares outstanding for SXT has been reduced compared to 5 years ago.
SXT has a better debt/assets ratio than last year.
SXT Yearly Shares OutstandingSXT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
SXT Yearly Total Debt VS Total AssetsSXT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

SXT has an Altman-Z score of 5.13. This indicates that SXT is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of SXT (5.13) is better than 95.29% of its industry peers.
The Debt to FCF ratio of SXT is 10.32, which is on the high side as it means it would take SXT, 10.32 years of fcf income to pay off all of its debts.
SXT has a Debt to FCF ratio of 10.32. This is in the better half of the industry: SXT outperforms 63.53% of its industry peers.
A Debt/Equity ratio of 0.62 indicates that SXT is somewhat dependend on debt financing.
SXT has a Debt to Equity ratio (0.62) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 10.32
Altman-Z 5.13
ROIC/WACC0.94
WACC8.63%
SXT Yearly LT Debt VS Equity VS FCFSXT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 4.34 indicates that SXT has no problem at all paying its short term obligations.
The Current ratio of SXT (4.34) is better than 89.41% of its industry peers.
SXT has a Quick Ratio of 1.74. This is a normal value and indicates that SXT is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.74, SXT is doing good in the industry, outperforming 71.76% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.34
Quick Ratio 1.74
SXT Yearly Current Assets VS Current LiabilitesSXT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

5

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 7.69% over the past year.
The Earnings Per Share has been growing slightly by 0.34% on average over the past years.
SXT shows a small growth in Revenue. In the last year, the Revenue has grown by 6.30%.
SXT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.32% yearly.
EPS 1Y (TTM)7.69%
EPS 3Y-1.4%
EPS 5Y0.34%
EPS Q2Q%8.86%
Revenue 1Y (TTM)6.3%
Revenue growth 3Y4.1%
Revenue growth 5Y3.32%
Sales Q2Q%1.99%

3.2 Future

The Earnings Per Share is expected to grow by 15.40% on average over the next years. This is quite good.
Based on estimates for the next years, SXT will show a small growth in Revenue. The Revenue will grow by 5.59% on average per year.
EPS Next Y12.07%
EPS Next 2Y13.22%
EPS Next 3Y15.4%
EPS Next 5YN/A
Revenue Next Year3.68%
Revenue Next 2Y4.41%
Revenue Next 3Y5.59%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SXT Yearly Revenue VS EstimatesSXT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
SXT Yearly EPS VS EstimatesSXT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 30.68 indicates a quite expensive valuation of SXT.
60.00% of the companies in the same industry are cheaper than SXT, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 26.25. SXT is around the same levels.
SXT is valuated rather expensively with a Price/Forward Earnings ratio of 24.49.
SXT's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. SXT is more expensive than 61.18% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of SXT to the average of the S&P500 Index (22.15), we can say SXT is valued inline with the index average.
Industry RankSector Rank
PE 30.68
Fwd PE 24.49
SXT Price Earnings VS Forward Price EarningsSXT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

67.06% of the companies in the same industry are cheaper than SXT, based on the Enterprise Value to EBITDA ratio.
SXT's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 59
EV/EBITDA 17.8
SXT Per share dataSXT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SXT does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of SXT may justify a higher PE ratio.
SXT's earnings are expected to grow with 15.40% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.54
PEG (5Y)91.42
EPS Next 2Y13.22%
EPS Next 3Y15.4%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.74%, SXT has a reasonable but not impressive dividend return.
SXT's Dividend Yield is comparable with the industry average which is at 3.75.
SXT's Dividend Yield is slightly below the S&P500 average, which is at 2.38.
Industry RankSector Rank
Dividend Yield 1.74%

5.2 History

The dividend of SXT has a limited annual growth rate of 2.28%.
SXT has been paying a dividend for at least 10 years, so it has a reliable track record.
SXT has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)2.28%
Div Incr Years0
Div Non Decr Years34
SXT Yearly Dividends per shareSXT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

SXT pays out 54.19% of its income as dividend. This is a bit on the high side, but may be sustainable.
SXT's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP54.19%
EPS Next 2Y13.22%
EPS Next 3Y15.4%
SXT Yearly Income VS Free CF VS DividendSXT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M
SXT Dividend Payout.SXT Dividend Payout, showing the Payout Ratio.SXT Dividend Payout.PayoutRetained Earnings

SENSIENT TECHNOLOGIES CORP

NYSE:SXT (6/2/2025, 4:01:40 PM)

After market: 94.49 0 (0%)

94.49

-0.04 (-0.04%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)04-25 2025-04-25/bmo
Earnings (Next)07-25 2025-07-25
Inst Owners93.24%
Inst Owner Change2.15%
Ins Owners1.26%
Ins Owner Change4.01%
Market Cap4.01B
Analysts83.33
Price Target97.92 (3.63%)
Short Float %3.03%
Short Ratio2.93
Dividend
Industry RankSector Rank
Dividend Yield 1.74%
Yearly Dividend1.65
Dividend Growth(5Y)2.28%
DP54.19%
Div Incr Years0
Div Non Decr Years34
Ex-Date05-12 2025-05-12 (0.41)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.2%
Min EPS beat(2)0.56%
Max EPS beat(2)3.84%
EPS beat(4)2
Avg EPS beat(4)-0.91%
Min EPS beat(4)-7.03%
Max EPS beat(4)3.84%
EPS beat(8)3
Avg EPS beat(8)-1.24%
EPS beat(12)6
Avg EPS beat(12)-0.54%
EPS beat(16)10
Avg EPS beat(16)0.38%
Revenue beat(2)1
Avg Revenue beat(2)-0.37%
Min Revenue beat(2)-1.29%
Max Revenue beat(2)0.54%
Revenue beat(4)2
Avg Revenue beat(4)-0.03%
Min Revenue beat(4)-1.29%
Max Revenue beat(4)1.15%
Revenue beat(8)3
Avg Revenue beat(8)-1.2%
Revenue beat(12)4
Avg Revenue beat(12)-1%
Revenue beat(16)6
Avg Revenue beat(16)-0.3%
PT rev (1m)12.28%
PT rev (3m)12.28%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.12%
EPS NY rev (1m)3.09%
EPS NY rev (3m)1.06%
Revenue NQ rev (1m)0.36%
Revenue NQ rev (3m)1.03%
Revenue NY rev (1m)0.93%
Revenue NY rev (3m)0.31%
Valuation
Industry RankSector Rank
PE 30.68
Fwd PE 24.49
P/S 2.56
P/FCF 59
P/OCF 30.16
P/B 3.66
P/tB 6.08
EV/EBITDA 17.8
EPS(TTM)3.08
EY3.26%
EPS(NY)3.86
Fwd EY4.08%
FCF(TTM)1.6
FCFY1.69%
OCF(TTM)3.13
OCFY3.32%
SpS36.86
BVpS25.79
TBVpS15.53
PEG (NY)2.54
PEG (5Y)91.42
Profitability
Industry RankSector Rank
ROA 6.13%
ROE 11.71%
ROCE 10.87%
ROIC 8.07%
ROICexc 8.21%
ROICexgc 10.78%
OM 12.93%
PM (TTM) 8.19%
GM 32.93%
FCFM 4.35%
ROA(3y)5.97%
ROA(5y)6.2%
ROE(3y)11.57%
ROE(5y)11.82%
ROIC(3y)8.07%
ROIC(5y)8.29%
ROICexc(3y)8.19%
ROICexc(5y)8.42%
ROICexgc(3y)10.89%
ROICexgc(5y)11.48%
ROCE(3y)10.98%
ROCE(5y)11.24%
ROICexcg growth 3Y-4.49%
ROICexcg growth 5Y6.73%
ROICexc growth 3Y-2.36%
ROICexc growth 5Y7.59%
OM growth 3Y-1.22%
OM growth 5Y6.81%
PM growth 3Y-2.37%
PM growth 5Y5.25%
GM growth 3Y-0.3%
GM growth 5Y0.81%
F-Score7
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 10.32
Debt/EBITDA 2.6
Cap/Depr 107.15%
Cap/Sales 4.16%
Interest Coverage 250
Cash Conversion 50.57%
Profit Quality 53.05%
Current Ratio 4.34
Quick Ratio 1.74
Altman-Z 5.13
F-Score7
WACC8.63%
ROIC/WACC0.94
Cap/Depr(3y)133.77%
Cap/Depr(5y)124.67%
Cap/Sales(3y)5.12%
Cap/Sales(5y)4.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.69%
EPS 3Y-1.4%
EPS 5Y0.34%
EPS Q2Q%8.86%
EPS Next Y12.07%
EPS Next 2Y13.22%
EPS Next 3Y15.4%
EPS Next 5YN/A
Revenue 1Y (TTM)6.3%
Revenue growth 3Y4.1%
Revenue growth 5Y3.32%
Sales Q2Q%1.99%
Revenue Next Year3.68%
Revenue Next 2Y4.41%
Revenue Next 3Y5.59%
Revenue Next 5YN/A
EBIT growth 1Y9.85%
EBIT growth 3Y2.83%
EBIT growth 5Y10.36%
EBIT Next Year44.62%
EBIT Next 3Y22.14%
EBIT Next 5YN/A
FCF growth 1Y186.14%
FCF growth 3Y5.07%
FCF growth 5Y-6.64%
OCF growth 1Y1241.52%
OCF growth 3Y2.67%
OCF growth 5Y-2.37%